Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Dosing Schedules in SBP
NCT00761098Phase 4Unknown
- Sponsor
- Weill Cornell Medicine
- Start
- May 2005
- Primary completion
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of albumin (human) in spontaneous bacterial peritonitis (SBP), sponsored by Weill Cornell Medicine. Status: unknown.
02
Drugs
albumin (human)
03
Conditions
spontaneous bacterial peritonitis (SBP)
Beyond the preview
Go deeper on NCT00761098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761098.